FORTELL RESEARCH INC. – Trademark Portfolio
Entity Type: 03
FORTELL RESEARCH INC. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 9 Nice Classification classes. Currently, 0 trademarks are registered and 4 are pending. The owner is based in NEW YORK, NY.
379 W. BROADWAY
NEW YORK, NY 10012
Showing of trademarks Trademarks
Trademark Classifications
FORTELL RESEARCH INC.'s trademark portfolio spans 9 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Advertising; business management; business administration; office functions
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does FORTELL RESEARCH INC. have?
FORTELL RESEARCH INC. has 7 U.S. trademarks filed with the USPTO. Of these, 4 pending, 3 abandoned.
What trademark classes does FORTELL RESEARCH INC. file in?
FORTELL RESEARCH INC. files trademarks across 9 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 9 (Computers & Electronics), Class 35 (Advertising & Business). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What is FORTELL RESEARCH INC.'s trademark registration success rate?
FORTELL RESEARCH INC. has a 0% trademark registration rate, with 0 out of 3 resolved applications resulting in successful registration. Currently, 4 applications are pending review.